• Register
  • Login

Iraqi Postgraduate Medical Journal

  1. Home
  2. A Novel Study of Predictive Utility of Serum Melatonin in Diagnosis of Systemic Sclerosis: A Case-Control Study

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

Copyrights and Licensing

Home

About Journal

Aim and Scope

Editorial Board

Peer Review Process

Copyrights and Licensing

Indexing and Abstracting

Plagiarism Policy

Author's Guide

Article processing charge (APC)

A Novel Study of Predictive Utility of Serum Melatonin in Diagnosis of Systemic Sclerosis: A Case-Control Study

    Author

    • Faiq I. Gorial
,
  • Article Information
  • Download
  • Export Citation
  • Statistics
  • Share

Abstract

ABSTRACT:
BACKGROUND:
Melatonin is a pineal gland hormone with complex roles in the pathogenesis of autoimmune disorders. Immune abnormalities and disturbed endocrine secretion have been reported in patients with systemic sclerosis (SSc). A possible role of melatonin in pathogenesis of SSc patients might be present
OBJECTIVE:
To assess the predictive utility of serum melatonin in diagnosis of SSc patients.
METHODS:
A case-control study conducted at Rheumatology Unit of Baghdad Teaching Hospital-Medical City from November 2015 to April 2016 on 40 SSc patients diagnosed according to the 1980 criteria for classification of systemic sclerosis or 2013 American College of Rheumatology/European League Against Rheumatism for the classification of systemic sclerosis criteria and compared with 40 healthy controls matched in age, sex, and body mass index. Patients with overlapping other inflammatory arthritis or connective tissue disease or autoimmune diseases were excluded. Serum melatonin was measured in both groups by enzyme-linked immunosorbent assay (ELISA).
RESULTS:
Mean level of serum melatonin concentration was significantly lower in patients compared with controls (Mean ± SEM of patients was 602.9 ± 30.69 vs 782.1 ± 43.66 pg/ml for controls, p=0.001). The optimum cut-off value of serum melatonin that differentiate between patients and controls was ≤ 810.8 pg/ml (AUC=0.72, p=0.0005). Validity of serum melatonin at the optimum cutoff value showed highest level of accuracy (75%) with sensitivity 87.5% and specificity 62.5% and if the test was positive and the clinical suspicion of prestest probability was 50% then we have 70% confidence that the patient has systemic sclerosis [ Positive predictive value (PPV) at pretest 50%=70%]. However, this confidence will increase to 95.5% if the clinical suspicion of pretest probability was 90% (PPV at pretest probability 90%=95.5%). Also, if the test was negative then we can exclude the disease with 97.8% with confidence [Negative predictive value (NPV) =97.8%].
CONCLUSION:
Serum melatonin was a valid measure to diagnose SSc.

Keywords

  • KEYWORDS
  • pineal gland
  • systemic sclerosis
  • XML
  • PDF 0 K
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
    • Article View: 327
    • PDF Download: 211
Iraqi Postgraduate Medical Journal
Volume 16, Issue 3
September 2017
Page 224-228
Files
  • XML
  • PDF 0 K
Share
Export Citation
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
Statistics
  • Article View: 327
  • PDF Download: 211

APA

I. Gorial, F. (2017). A Novel Study of Predictive Utility of Serum Melatonin in Diagnosis of Systemic Sclerosis: A Case-Control Study. Iraqi Postgraduate Medical Journal, 16(3), 224-228.

MLA

Faiq I. Gorial. "A Novel Study of Predictive Utility of Serum Melatonin in Diagnosis of Systemic Sclerosis: A Case-Control Study". Iraqi Postgraduate Medical Journal, 16, 3, 2017, 224-228.

HARVARD

I. Gorial, F. (2017). 'A Novel Study of Predictive Utility of Serum Melatonin in Diagnosis of Systemic Sclerosis: A Case-Control Study', Iraqi Postgraduate Medical Journal, 16(3), pp. 224-228.

VANCOUVER

I. Gorial, F. A Novel Study of Predictive Utility of Serum Melatonin in Diagnosis of Systemic Sclerosis: A Case-Control Study. Iraqi Postgraduate Medical Journal, 2017; 16(3): 224-228.

  • Home
  • About Journal
  • Editorial Board
  • Submit Manuscript
  • Contact Us
  • Glossary
  • Sitemap

News

This work is licensed under          CC BY 4.0    

 

 

Newsletter Subscription

Subscribe to the journal newsletter and receive the latest news and updates

© Journal Management System. Powered by iJournalPro.com